0001104659-24-122795.txt : 20241126 0001104659-24-122795.hdr.sgml : 20241126 20241126063815 ACCESSION NUMBER: 0001104659-24-122795 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241126 DATE AS OF CHANGE: 20241126 EFFECTIVENESS DATE: 20241126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530477 FILM NUMBER: 241498112 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 D 1 primary_doc.xml X0708 D LIVE 0001130166 Cyclacel Pharmaceuticals, Inc. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ NEW JERSEY 07922 908-517-7330 DELAWARE MolecuRx, Inc. CDR Therapeutics, Inc. Xcyte Therapies, Inc XCYTE THERAPIES INC Corporation true Spiro Rombotis c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Executive Officer Director Paul McBarron c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Executive Officer Director Christopher Henney c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Samuel Barker c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Kenneth Ferguson c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Robert Spiegel c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Brian Schwartz c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Karin Walker c/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ NEW JERSEY 07922 Director Biotechnology Decline to Disclose 06b false 2024-11-14 false true true true false 0 H.C. Wainwright & Co. 000000375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 NY NEW YORK false 2062112 2062112 0 false 1 189969 0 The Company (a) paid Wainwright an aggregate cash fee of 7% of the gross proceeds, a management fee of 1% of the gross proceeds, expense reimbursement of $25,000 and (b) issued them warrants to purchase up to 298,137 shares. 0 false Cyclacel Pharmaceuticals, Inc. /s/ Paul McBarron Paul McBarron Executive Vice President-Finance, CFO and COO 2024-11-26